Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy responseShengshan Xu, Zhuming Lu, Dongxi Zhang et al.|BMC Cancer|2024Cited by 50
Multi‑omics identification of a signature based on malignant cell-associated ligand–receptor genes for lung adenocarcinomaShengshan Xu, Zhuming Lu, Haoxuan Ying et al.|BMC Cancer|2024Cited by 36